Physician profile
David J Zelman
NPI 1366550337
$999.82
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $24.85 · 2021: $383 · 2023: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $286.32 | 2019-2021 | |
| Radius Health, INC. | $144.36 | 2019 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $102.19 | 2019 | |
| Ucb, INC. | $41.18 | 2020-2023 | Cimzia |
| Astrazeneca Pharmaceuticals LP | $40.56 | 2023 | Saphnelo |
| Amgen INC. | $38.25 | 2019-2023 | Avsola, Amjevita |
| Abbvie INC. | $28.54 | 2023 | Rinvoq |
| Lilly USA, LLC | $27.34 | 2019-2023 | Taltz |
| Fresenius Kabi USA, LLC | $15.98 | 2023 | Idacio |
| Janssen Biotech, INC. | $14.05 | 2019 | |
| Pfizer INC. | $11.05 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.